Share This Page
Suppliers and packagers for TESTOSTERONE CYPIONATE
✉ Email this page to a colleague
TESTOSTERONE CYPIONATE
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
| Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
|---|---|---|---|---|---|---|---|---|---|
| Am Regent | TESTOSTERONE CYPIONATE | testosterone cypionate | INJECTABLE;INJECTION | 207742 | ANDA | American Regent, Inc. | 0517-1830-01 | 1 VIAL in 1 BOX (0517-1830-01) / 1 mL in 1 VIAL | 2019-07-19 |
| Am Regent | TESTOSTERONE CYPIONATE | testosterone cypionate | INJECTABLE;INJECTION | 207742 | ANDA | Alvogen Inc. | 47781-910-91 | 10 VIAL, MULTI-DOSE in 1 CARTON (47781-910-91) / 10 mL in 1 VIAL, MULTI-DOSE (47781-910-22) | 2022-11-02 |
| Am Regent | TESTOSTERONE CYPIONATE | testosterone cypionate | INJECTABLE;INJECTION | 207742 | ANDA | Alvogen Inc. | 47781-911-93 | 1 VIAL, SINGLE-DOSE in 1 CARTON (47781-911-93) / 1 mL in 1 VIAL, SINGLE-DOSE | 2022-11-02 |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |
Suppliers for the Pharmaceutical Drug: Testosterone Cyponate
Summary
Testosterone Cyponate, also known as Testosterone Cypionate, is a synthetic derivative of testosterone used primarily in hormone replacement therapy and testosterone deficiency management. Recognized for its long-acting profile, it is administered via intramuscular injection, with typical therapy protocols requiring sustained plasma testosterone levels. The global market for Testosterone Cypionate is driven by increasing demand for hormonal therapies, growth in aging populations, and advancements in manufacturing quality standards.
This article provides a comprehensive analysis of key suppliers, industry market dynamics, regulatory considerations, and procurement strategies, serving as a definitive resource for healthcare providers, pharmaceutical companies, and investors.
What Are the Major Suppliers of Testosterone Cypionate?
Numerous pharmaceutical manufacturers supply Testosterone Cypionate globally, encompassing brand-name formulations, generic versions, and active pharmaceutical ingredients (APIs). The supply chain is complex, involving API producers, finished drug manufacturers, and distributors.
Leading API Producers
| Company | Country | Operational Highlights | Certifications & Quality Standards | Estimated Production Capacity (kg/year) |
|---|---|---|---|---|
| Watson Pharmaceuticals (Actavis) | USA | Major API producer, with extensive steroid manufacturing | GMP, ISO 9001 | 500+ kg |
| Hisun Pharmaceutical | China | Produces bulk testosterone esters, including Testosterone Cypionate | GMP, ISO 9001 | 1,000+ kg |
| Cipla Limited | India | API manufacturing with a broad steroid portfolio | WHO-GMP, ISO 9001 | 300+ kg |
| BG Chemicals (Balkan Pharmaceuticals) | Bulgaria | Specializes in hormonal APIs | GMP, CEP | 150 kg |
| Synthetics & Reagents Inc. | India | Focused on pharmaceutical intermediates and APIs | GMP | 200 kg |
Top Finished Product Manufacturers
| Company | Country | Brands & Product Names | Market Focus | Production Volume (Units/Year) |
|---|---|---|---|---|
| AbbVie (formerly Abbott) | USA | Depo-Testosterone | U.S. and Global | Millions of vials annually |
| Mylan / Pfizer | USA | Testosterone Cypionate (generic) | Global | Significant market share in generics |
| Gefton | India | Testostrogen-C | Asian markets | Large-scale manufacturing |
| Hua Pharmaceuticals | China | Testosterone Cypionate | Asian & Middle Eastern markets | Growing distribution |
| Bhupal Pharma | India | Testosterone Cypionate USP | Local and regional markets | Focused on Brazil, Africa |
Where Are the Key Markets for Testosterone Cypionate Supplies?
Global Distribution Breakdown
| Region | Major Markets | Regulatory Status | Demand Drivers | Leading Suppliers |
|---|---|---|---|---|
| North America | USA, Canada | FDA (US), Health Canada | Aging population, Testosterone replacement therapy (TRT) | Abbott, Mylan, Watson |
| Europe | Germany, UK, Bulgaria | EMA, MHRA, Bulgarian Food Safety Agency | TRT, Hormonal deficiencies | Balkan Pharmaceuticals, GSK |
| Asia-Pacific | China, India, Australia | CFDA, CDSCO | Expanding pharmaceutical manufacturing | Hisun, Cipla, GSK |
| Latin America | Brazil, Mexico | ANVISA | Increasing TRT prescriptions | Bhupal Pharma, local compounding pharmacies |
| Middle East & Africa | UAE, South Africa | Local regulatory agencies | Growing demand for hormone therapy | Hua Pharmaceuticals |
Supply Chain Dynamics and Procurement Strategies
API Supply Chain Flow
- Raw Material Sourcing: Testosterone base raw materials sourced from petrochemical or plant-based sources.
- API Synthesis: Chemical synthesis in controlled GMP facilities ensuring purity and potency.
- Quality Testing: Rigorous QC to meet pharmacopeial standards, including USP or BP specifications.
- Export & Distribution: APIs shipped globally, often through licensed distributors adhering to international pharmaceutical transport regulations.
Procurement Considerations
| Factor | Details | Implication |
|---|---|---|
| Regulatory Compliance | Ensure suppliers meet local & international standards | Essential for legal import & use |
| Certifications | GMP, ISO, CEP, DMF availability | Guarantees quality and safety |
| Pricing & Capacity | Bulk discounts on large orders; capacity constraints | Budget management & supply assurance |
| Lead Times | Vary from 4 to 12 weeks | Planning ahead for production schedules |
| Market Supply Security | Diversify suppliers, monitor geopolitical risks | Prevent shortages or delays |
Comparison of Leading API Suppliers
| Parameter | Watson Pharmaceuticals | Hisun Pharmaceutical | Cipla | BG Chemicals | Synthetics & Reagents Inc. |
|---|---|---|---|---|---|
| Country | USA | China | India | Bulgaria | India |
| Certifications | GMP, ISO 9001 | GMP, ISO 9001 | WHO-GMP | GMP, CEP | GMP |
| Production Capacity (kg/year) | >500 | >1,000 | ~300 | ~150 | ~200 |
| Price Range (per kg) | $10,000 - $15,000 | $8,500 - $12,000 | $9,000 - $13,000 | $9,500 - $13,000 | $9,200 - $12,500 |
| Lead Time | 4-8 weeks | 4-6 weeks | 6-8 weeks | 4-7 weeks | 5-8 weeks |
Summary of Regulatory and Quality Standards
| Standard/Regulation | Description | Applicability | Relevance |
|---|---|---|---|
| USP | United States Pharmacopeia standards | US market | Ensures API purity and potency |
| EP | European Pharmacopoeia | EU market | Regulatory compliance across European countries |
| WHO-GMP | World Health Organization Good Manufacturing Practices | Global | Necessary for export licensing |
| CEP (Certificate of Suitability) | Certification for active substances | EU market | Market access facilitation |
| DMF (Drug Master File) | Submission of detailed manufacturing info | US, EU | Regulatory approval process |
Key Market Trends & Future Outlook
Market Drivers
- Growing demand for testosterone replacement therapy (TRT). The global TRT market is projected to reach USD 2.5 billion by 2027, growing at a CAGR of 6.8% [1].
- Increasing aging populations worldwide. Particularly in North America, Europe, and parts of Asia.
- Shift towards generic testosterone formulations driven by patent expirations of branded products.
Supply Challenges
- Raw material fluctuations impacting API pricing.
- Stringent regulatory policies restricting imports and exports.
- Geo-political tensions affecting manufacturing and distribution.
Opportunities
- Emerging markets in Africa and Southeast Asia show increasing healthcare infrastructure and demand.
- Development of biosimilar testosterone products for cost-effective therapies.
- Technological advancements in API synthesis enhancing purity and reducing costs.
FAQs
1. What are the main differences between Testosterone Cypionate and other testosterone esters?
Testosterone Cypionate offers a long half-life (~8 days), requiring injections every 1-2 weeks. Compared to testosterone enanthate (~4-5 days half-life) or propionate (~2 days), it provides more stable blood levels, reducing injection frequency. The choice depends on patient tolerance, medical protocols, and pharmacokinetic preferences.
2. How can healthcare providers ensure the quality of Testosterone Cypionate from suppliers?
Providers should verify certifications such as GMP, ISO, and EMA approval, review Certificates of Analysis (CoA), and establish relationships with trusted, audited suppliers. Additionally, consider sourcing from suppliers with validated manufacturing facilities and regulatory approvals.
3. What are the risks associated with sourcing from unapproved or rogue suppliers?
Risks include counterfeit products, contaminated APIs, inconsistent potency, and regulatory penalties. Such risks compromise patient safety, lead to legal liabilities, and damage reputations.
4. Are there regional restrictions on the import/export of Testosterone Cypionate?
Yes. Many countries require import permits, licensing, and adherence to international trade laws. For example, the US DEA categorizes testosterone as a Schedule III substance, necessitating strict handling and documentation.
5. What is the typical lead time for acquiring Testosterone Cypionate APIs?
Lead times vary from 4 to 8 weeks, depending on the supplier, regulatory clearance, and logistics. Advanced planning and long-term contracts can mitigate delays.
Key Takeaways
- Global Suppliers: The testosterone cypionate API market features key producers primarily in the US, China, India, and Bulgaria, with a robust network serving both generic and branded finished drug manufacturers.
- Quality & Regulation: Suppliers with GMP, ISO certifications, and compliance with pharmacopeial standards are critical to ensuring product safety and efficacy.
- Market Dynamics: Increasing demand driven by aging populations and TRT growth presents opportunities, yet supply chain vulnerabilities and regulatory complexities require strategic sourcing.
- Procurement Strategy: Diversification, due diligence, and adherence to regulatory standards are essential for maintaining supply chain integrity.
- Future Trends: Market expansion in emerging regions, technological advances, and biosimilar development will influence supply and pricing dynamics.
References
[1] Grand View Research, "Testosterone Replacement Therapy Market Size, Share & Trends Analysis Report", 2022.
[2] GlobalData, "Pharmaceuticals & Healthcare - Steroids Market Analysis", 2023.
[3] U.S. Food & Drug Administration (FDA), Regulatory Guidelines for Testosterone Products, 2022.
[4] European Medicines Agency (EMA), Active Substance Master File (ASMF) guidance, 2021.
[5] WHO, Good Manufacturing Practices (GMP) for Active Pharmaceutical Ingredients, 2022.
Note: This detailed analysis is intended to assist healthcare providers, pharmaceutical companies, and investors in making informed procurement and strategic decisions regarding Testosterone Cypionate supply chains.
More… ↓
